(HealthDay)—For stable warfarin-treated patients, extended international normalized ratio (INR) testing can be successfully and safely implemented, according to a study published online May 15 ...

As compared with venous plasma testing, point-of-care INR measuring devices allow greater testing frequency and patient involvement and may improve clinical outcomes.

According to Future Market Insights, the global INR Test Meter Market Size was worth around US$ 1.3 billion in 2022 and is expected to rise at a CAGR of close to 6.3% over the forecast period, ...

However, home testing was associated with improvements in time within the therapeutic INR range, patient satisfaction with anticoagulation therapy, and quality of life.

Musialowski: Home INR testing is administered by an independent vendor and requires insurance pre-certification. There was a registration and application process, which delayed implementation.

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...